top of page

eXecon Speaker

CYBERIA_1.png
NeuroRX, Inc.
More than 500 people with bipolar disease die each day from suicidal crisis across the OECD countries. NeuroRx has demonstrated human proof of concept for a first-in-class, rapid-onset, sustained therapy therapy for this condition, which currently has no approved treatment.
Sold to

EBAFB

CYBERIA_1.png

2015

NeuroRX, Inc.
bottom of page